<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-08-12" version="188">
<accession>Q16820</accession>
<accession>B7ZM35</accession>
<accession>B9EGL6</accession>
<accession>Q670J1</accession>
<name>MEP1B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Meprin A subunit beta</fullName>
<ecNumber>3.4.24.63</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Endopeptidase-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Meprin B</fullName>
</alternativeName>
<alternativeName>
<fullName>N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta</fullName>
</alternativeName>
<alternativeName>
<fullName>PABA peptide hydrolase</fullName>
</alternativeName>
<alternativeName>
<fullName>PPH beta</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MEP1B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Eur. J. Biochem." volume="247" first="920" last="932">
<title>Polarised expression of human intestinal N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin) alpha and beta subunits in Madin-Darby canine kidney cells.</title>
<authorList>
<person name="Eldering J.A."/>
<person name="Gruenberg J."/>
<person name="Hahn D."/>
<person name="Croes H.J."/>
<person name="Fransen J.A."/>
<person name="Sterchi E.E."/>
</authorList>
<dbReference type="PubMed" id="9288916"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1997.00920.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 62-105</scope>
<scope>VARIANT LEU-695</scope>
<source>
<tissue>Intestine</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<title>Expression of human meprin beta.</title>
<authorList>
<person name="Haun R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Small intestine</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-695</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="FEBS Lett." volume="335" first="367" last="375">
<title>Cloning of the PABA peptide hydrolase alpha subunit (PPH alpha) from human small intestine and its expression in COS-1 cells.</title>
<authorList>
<person name="Dumermuth E."/>
<person name="Eldering J.A."/>
<person name="Gruenberg J."/>
<person name="Jiang W."/>
<person name="Sterchi E.E."/>
</authorList>
<dbReference type="PubMed" id="8262185"/>
<dbReference type="DOI" id="10.1016/0014-5793(93)80421-p"/>
</citation>
<scope>PROTEIN SEQUENCE OF 62-79</scope>
<source>
<tissue>Small intestine mucosa</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Eur. J. Biochem." volume="261" first="421" last="429">
<title>N-Benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase beta (human meprinbeta). A 13-amino-acid sequence is required for proteolytic processing and subsequent secretion.</title>
<authorList>
<person name="Pischitzis A."/>
<person name="Hahn D."/>
<person name="Leuenberger B."/>
<person name="Sterchi E.E."/>
</authorList>
<dbReference type="PubMed" id="10215852"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.1999.00268.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Biochem. J." volume="369" first="659" last="665">
<title>Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion.</title>
<authorList>
<person name="Leuenberger B."/>
<person name="Hahn D."/>
<person name="Pischitzis A."/>
<person name="Hansen M.K."/>
<person name="Sterchi E.E."/>
</authorList>
<dbReference type="PubMed" id="12387727"/>
<dbReference type="DOI" id="10.1042/bj20021398"/>
</citation>
<scope>GLYCOSYLATION AT SER-593; THR-594; THR-599 AND SER-603</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF 595-GLN--LEU-607</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="42545" last="42550">
<title>Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.</title>
<authorList>
<person name="Villa J.P."/>
<person name="Bertenshaw G.P."/>
<person name="Bond J.S."/>
</authorList>
<dbReference type="PubMed" id="12888571"/>
<dbReference type="DOI" id="10.1074/jbc.m303718200"/>
</citation>
<scope>CLEAVAGE OF GASTRIN</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>MUTAGENESIS OF LYS-248</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="31371" last="31377">
<title>Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.</title>
<authorList>
<person name="Banerjee S."/>
<person name="Bond J.S."/>
</authorList>
<dbReference type="PubMed" id="18786924"/>
<dbReference type="DOI" id="10.1074/jbc.m802814200"/>
</citation>
<scope>CLEAVAGE OF IL18</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E2153" last="E2153">
<title>The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion.</title>
<authorList>
<person name="Huguenin M."/>
<person name="Muller E.J."/>
<person name="Trachsel-Rosmann S."/>
<person name="Oneda B."/>
<person name="Ambort D."/>
<person name="Sterchi E.E."/>
<person name="Lottaz D."/>
</authorList>
<dbReference type="PubMed" id="18478055"/>
<dbReference type="DOI" id="10.1371/journal.pone.0002153"/>
</citation>
<scope>CLEAVAGE OF E-CADHERIN</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="8599" last="8607">
<title>Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.</title>
<authorList>
<person name="Hedrich J."/>
<person name="Lottaz D."/>
<person name="Meyer K."/>
<person name="Yiallouros I."/>
<person name="Jahnen-Dechent W."/>
<person name="Stocker W."/>
<person name="Becker-Pauly C."/>
</authorList>
<dbReference type="PubMed" id="20806899"/>
<dbReference type="DOI" id="10.1021/bi1004238"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="Matrix Biol." volume="29" first="31" last="42">
<title>Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.</title>
<authorList>
<person name="Ambort D."/>
<person name="Brellier F."/>
<person name="Becker-Pauly C."/>
<person name="Stocker W."/>
<person name="Andrejevic-Blant S."/>
<person name="Chiquet M."/>
<person name="Sterchi E.E."/>
</authorList>
<dbReference type="PubMed" id="19748582"/>
<dbReference type="DOI" id="10.1016/j.matbio.2009.08.007"/>
</citation>
<scope>CLEAVAGE OF TNC</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="Mol. Cell. Proteomics" volume="10" first="M111.009233.01" last="M111.009233.19">
<title>Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates.</title>
<authorList>
<person name="Becker-Pauly C."/>
<person name="Barre O."/>
<person name="Schilling O."/>
<person name="Auf dem Keller U."/>
<person name="Ohler A."/>
<person name="Broder C."/>
<person name="Schutte A."/>
<person name="Kappelhoff R."/>
<person name="Stocker W."/>
<person name="Overall C.M."/>
</authorList>
<dbReference type="PubMed" id="21693781"/>
<dbReference type="DOI" id="10.1074/mcp.m111.009233"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>CLEAVAGE OF FGF19; KLK7 AND VGFA</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Cell. Mol. Life Sci." volume="70" first="309" last="333">
<title>The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10.</title>
<authorList>
<person name="Jefferson T."/>
<person name="Auf dem Keller U."/>
<person name="Bellac C."/>
<person name="Metz V.V."/>
<person name="Broder C."/>
<person name="Hedrich J."/>
<person name="Ohler A."/>
<person name="Maier W."/>
<person name="Magdolen V."/>
<person name="Sterchi E."/>
<person name="Bond J.S."/>
<person name="Jayakumar A."/>
<person name="Traupe H."/>
<person name="Chalaris A."/>
<person name="Rose-John S."/>
<person name="Pietrzik C.U."/>
<person name="Postina R."/>
<person name="Overall C.M."/>
<person name="Becker-Pauly C."/>
</authorList>
<dbReference type="PubMed" id="22940918"/>
<dbReference type="DOI" id="10.1007/s00018-012-1106-2"/>
</citation>
<scope>CLEAVAGE OF ADAM10</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="16131" last="16136">
<title>Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane.</title>
<authorList>
<person name="Arolas J.L."/>
<person name="Broder C."/>
<person name="Jefferson T."/>
<person name="Guevara T."/>
<person name="Sterchi E.E."/>
<person name="Bode W."/>
<person name="Stocker W."/>
<person name="Becker-Pauly C."/>
<person name="Gomis-Ruth F.X."/>
</authorList>
<dbReference type="PubMed" id="22988105"/>
<dbReference type="DOI" id="10.1073/pnas.1211076109"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 25-614</scope>
<scope>GLYCOSYLATION AT ASN-218; ASN-254; ASN-370; ASN-436; ASN-445; ASN-547 AND ASN-592</scope>
<scope>DISULFIDE BONDS</scope>
<scope>COFACTOR</scope>
<scope>ZINC-BINDING SITES</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="1921" last="1929">
<title>Diagnostic exome sequencing in persons with severe intellectual disability.</title>
<authorList>
<person name="de Ligt J."/>
<person name="Willemsen M.H."/>
<person name="van Bon B.W."/>
<person name="Kleefstra T."/>
<person name="Yntema H.G."/>
<person name="Kroes T."/>
<person name="Vulto-van Silfhout A.T."/>
<person name="Koolen D.A."/>
<person name="de Vries P."/>
<person name="Gilissen C."/>
<person name="del Rosario M."/>
<person name="Hoischen A."/>
<person name="Scheffer H."/>
<person name="de Vries B.B."/>
<person name="Brunner H.G."/>
<person name="Veltman J.A."/>
<person name="Vissers L.E."/>
</authorList>
<dbReference type="PubMed" id="23033978"/>
<dbReference type="DOI" id="10.1056/nejmoa1206524"/>
</citation>
<scope>VARIANT ALA-324</scope>
</reference>
<comment type="function">
<text evidence="17">Membrane metallopeptidase that sheds many membrane-bound proteins. Exhibits a strong preference for acidic amino acids at the P1' position. Known substrates include: FGF19, VGFA, IL1B, IL18, procollagen I and III, E-cadherin, KLK7, gastrin, ADAM10, tenascin-C. The presence of several pro-inflammatory cytokine among substrates implicate MEP1B in inflammation. It is also involved in tissue remodeling due to its capability to degrade extracellular matrix components.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="17">
<text>Hydrolysis of proteins, including azocasein, and peptides. Hydrolysis of 5-His-|-Leu-6, 6-Leu-|-Cys-7, 14-Ala-|-Leu-15 and 19-Cys-|-Gly-20 bonds in insulin B chain.</text>
<dbReference type="EC" id="3.4.24.63"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="8 19">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="8 19">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="16 18">Strongly inhibited by fetuin-A/AHSG.</text>
</comment>
<comment type="subunit">
<text evidence="3">Homotetramer consisting of disulfide-linked beta subunits, or heterotetramer of two alpha and two beta subunits formed by non-covalent association of two disulfide-linked heterodimers (By similarity). Interacts with MBL2 through its carbohydrate moiety. This interaction may inhibit its catalytic activity (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968418">
<id>Q16820</id>
</interactant>
<interactant intactId="EBI-968418">
<id>Q16820</id>
<label>MEP1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968418">
<id>Q16820</id>
</interactant>
<interactant intactId="EBI-1382326">
<id>P14780</id>
<label>MMP9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968418">
<id>Q16820</id>
</interactant>
<interactant intactId="EBI-4289938">
<id>P19075</id>
<label>TSPAN8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19">Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Secreted</location>
</subcellularLocation>
<text evidence="19">Homodimers are essentially membrane bound but may also be shed from the surface by ADAM-10 and ADAM-17.</text>
</comment>
<comment type="tissue specificity">
<text evidence="10">The major site of expression is the brush border membrane of small intestinal and kidney epithelial cells.</text>
</comment>
<comment type="PTM">
<text>N-glycosylated; contains high mannose and/or complex biantennary structures.</text>
</comment>
<comment type="PTM">
<text evidence="9 11 13 14 15 17 18">O-glycosylation protect the C-terminal region from proteolytic cleavage and diminish secretion, this seems to be specific to human.</text>
</comment>
<comment type="PTM">
<text>Proteolytically activated by trypsin in the intestinal lumen and kallikrein-related peptidases in other tissues.</text>
</comment>
<dbReference type="EC" id="3.4.24.63"/>
<dbReference type="EMBL" id="X81333">
<property type="protein sequence ID" value="CAA57107.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY695931">
<property type="protein sequence ID" value="AAU05377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136559">
<property type="protein sequence ID" value="AAI36560.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC144244">
<property type="protein sequence ID" value="AAI44245.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45846.1"/>
<dbReference type="PIR" id="S49383">
<property type="entry name" value="HYHUMB"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295100.1">
<property type="nucleotide sequence ID" value="NM_001308171.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005916.2">
<property type="nucleotide sequence ID" value="NM_005925.2"/>
</dbReference>
<dbReference type="PDB" id="4GWM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=23-614"/>
</dbReference>
<dbReference type="PDB" id="4GWN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=62-614"/>
</dbReference>
<dbReference type="PDBsum" id="4GWM"/>
<dbReference type="PDBsum" id="4GWN"/>
<dbReference type="SMR" id="Q16820"/>
<dbReference type="BioGRID" id="110388">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="CORUM" id="Q16820"/>
<dbReference type="DIP" id="DIP-34900N"/>
<dbReference type="IntAct" id="Q16820">
<property type="interactions" value="39"/>
</dbReference>
<dbReference type="MINT" id="Q16820"/>
<dbReference type="STRING" id="9606.ENSP00000269202"/>
<dbReference type="BindingDB" id="Q16820"/>
<dbReference type="ChEMBL" id="CHEMBL4105879"/>
<dbReference type="MEROPS" id="M12.004"/>
<dbReference type="TCDB" id="8.A.77.2.1">
<property type="family name" value="the sheddase (sheddase) family"/>
</dbReference>
<dbReference type="GlyGen" id="Q16820">
<property type="glycosylation" value="12 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q16820"/>
<dbReference type="PhosphoSitePlus" id="Q16820"/>
<dbReference type="BioMuta" id="MEP1B"/>
<dbReference type="DMDM" id="296439304"/>
<dbReference type="PaxDb" id="Q16820"/>
<dbReference type="PeptideAtlas" id="Q16820"/>
<dbReference type="PRIDE" id="Q16820"/>
<dbReference type="ProteomicsDB" id="61079"/>
<dbReference type="Antibodypedia" id="22196">
<property type="antibodies" value="69 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000269202">
<property type="protein sequence ID" value="ENSP00000269202"/>
<property type="gene ID" value="ENSG00000141434"/>
</dbReference>
<dbReference type="GeneID" id="4225"/>
<dbReference type="KEGG" id="hsa:4225"/>
<dbReference type="UCSC" id="uc002kxj.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4225"/>
<dbReference type="DisGeNET" id="4225"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141434.11"/>
<dbReference type="GeneCards" id="MEP1B"/>
<dbReference type="HGNC" id="HGNC:7020">
<property type="gene designation" value="MEP1B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000141434">
<property type="expression patterns" value="Tissue enriched (intestine)"/>
</dbReference>
<dbReference type="MIM" id="600389">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16820"/>
<dbReference type="OpenTargets" id="ENSG00000141434"/>
<dbReference type="PharmGKB" id="PA30754"/>
<dbReference type="eggNOG" id="KOG3714">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183111"/>
<dbReference type="InParanoid" id="Q16820"/>
<dbReference type="KO" id="K08606"/>
<dbReference type="OMA" id="YVSIIWD"/>
<dbReference type="OrthoDB" id="241999at2759"/>
<dbReference type="PhylomeDB" id="Q16820"/>
<dbReference type="TreeFam" id="TF315280"/>
<dbReference type="BRENDA" id="3.4.24.63">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q16820"/>
<dbReference type="SignaLink" id="Q16820"/>
<dbReference type="BioGRID-ORCS" id="4225">
<property type="hits" value="6 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="MEP1B"/>
<dbReference type="GenomeRNAi" id="4225"/>
<dbReference type="Pharos" id="Q16820">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q16820"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 18"/>
</dbReference>
<dbReference type="RNAct" id="Q16820">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141434">
<property type="expression patterns" value="Expressed in jejunal mucosa and 115 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q16820">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q16820">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017090">
<property type="term" value="C:meprin A complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004222">
<property type="term" value="F:metalloendopeptidase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:1901998">
<property type="term" value="P:toxin transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd06263">
<property type="entry name" value="MAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04282">
<property type="entry name" value="ZnMc_meprin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.210.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.390.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013320">
<property type="entry name" value="ConA-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000742">
<property type="entry name" value="EGF-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000998">
<property type="entry name" value="MAM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002083">
<property type="entry name" value="MATH/TRAF_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008294">
<property type="entry name" value="Meprin"/>
</dbReference>
<dbReference type="InterPro" id="IPR034302">
<property type="entry name" value="Meprin_beta"/>
</dbReference>
<dbReference type="InterPro" id="IPR024079">
<property type="entry name" value="MetalloPept_cat_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001506">
<property type="entry name" value="Peptidase_M12A"/>
</dbReference>
<dbReference type="InterPro" id="IPR006026">
<property type="entry name" value="Peptidase_Metallo"/>
</dbReference>
<dbReference type="InterPro" id="IPR008974">
<property type="entry name" value="TRAF-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR034038">
<property type="entry name" value="ZnMP_meprin"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10127:SF814">
<property type="entry name" value="PTHR10127:SF814"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01400">
<property type="entry name" value="Astacin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00629">
<property type="entry name" value="MAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001196">
<property type="entry name" value="Meprin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00480">
<property type="entry name" value="ASTACIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00020">
<property type="entry name" value="MAMDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00137">
<property type="entry name" value="MAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00061">
<property type="entry name" value="MATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00235">
<property type="entry name" value="ZnMc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49599">
<property type="entry name" value="SSF49599"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49899">
<property type="entry name" value="SSF49899"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51864">
<property type="entry name" value="ASTACIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50026">
<property type="entry name" value="EGF_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00740">
<property type="entry name" value="MAM_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50060">
<property type="entry name" value="MAM_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50144">
<property type="entry name" value="MATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00142">
<property type="entry name" value="ZINC_PROTEASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0245">EGF-like domain</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0482">Metalloprotease</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0865">Zymogen</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="propeptide" id="PRO_0000028883" evidence="21 22">
<location>
<begin position="23"/>
<end position="61"/>
</location>
</feature>
<feature type="chain" description="Meprin A subunit beta" id="PRO_0000028884">
<location>
<begin position="62"/>
<end position="701"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="23"/>
<end position="652"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="653"/>
<end position="673"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="674"/>
<end position="701"/>
</location>
</feature>
<feature type="domain" description="Peptidase M12A" evidence="8">
<location>
<begin position="62"/>
<end position="256"/>
</location>
</feature>
<feature type="domain" description="MAM" evidence="6">
<location>
<begin position="260"/>
<end position="429"/>
</location>
</feature>
<feature type="domain" description="MATH" evidence="7">
<location>
<begin position="430"/>
<end position="585"/>
</location>
</feature>
<feature type="domain" description="EGF-like" evidence="5">
<location>
<begin position="604"/>
<end position="644"/>
</location>
</feature>
<feature type="region of interest" description="Required for proteolytic processing">
<location>
<begin position="595"/>
<end position="607"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="153"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen; catalytic" evidence="1 8 19">
<location>
<position position="152"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen; catalytic" evidence="1 8 19">
<location>
<position position="156"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen; catalytic" evidence="1 8 19">
<location>
<position position="162"/>
</location>
</feature>
<feature type="site" description="Mediates preference for acidic residues at subsite P1'">
<location>
<position position="238"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="218"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="254"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="370"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="421"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="436"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="445"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="547"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="592"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="4">
<location>
<position position="593"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="4">
<location>
<position position="594"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="4">
<location>
<position position="599"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="4">
<location>
<position position="603"/>
</location>
</feature>
<feature type="disulfide bond" evidence="8 19">
<location>
<begin position="103"/>
<end position="255"/>
</location>
</feature>
<feature type="disulfide bond" evidence="8 19">
<location>
<begin position="124"/>
<end position="144"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 19">
<location>
<begin position="265"/>
<end position="427"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="5">
<location>
<position position="273"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="5 19">
<location>
<position position="305"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="5">
<location>
<position position="492"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="608"/>
<end position="619"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="613"/>
<end position="628"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="630"/>
<end position="643"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_069387" evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9959396." id="VAR_057064">
<original>V</original>
<variation>M</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs616114." id="VAR_057065" evidence="12 22">
<original>P</original>
<variation>L</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased activity toward gastrin." evidence="11">
<original>K</original>
<variation>Y</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes secretion." evidence="10">
<location>
<begin position="595"/>
<end position="607"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AA sequence." ref="4" evidence="23">
<original>W</original>
<variation>S</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AA sequence." ref="4" evidence="23">
<original>T</original>
<variation>P</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAU05377 and 3; AAI36560/AAI44245." ref="2 3" evidence="23">
<original>S</original>
<variation>P</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA57107." ref="1" evidence="23">
<location>
<position position="698"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="29"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="37"/>
<end position="43"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="73"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="105"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="113"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="122"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="140"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="147"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="185"/>
<end position="188"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="213"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="232"/>
<end position="236"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="243"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="259"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="285"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="292"/>
<end position="294"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="299"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="311"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="324"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="339"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="354"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="366"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="398"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="412"/>
<end position="425"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="429"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="460"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="469"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="485"/>
<end position="487"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="494"/>
<end position="501"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="514"/>
<end position="519"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="527"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="536"/>
<end position="539"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="541"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="550"/>
<end position="564"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="565"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="573"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="578"/>
<end position="587"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="589"/>
<end position="591"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GWM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GWN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00076"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00128"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00129"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01211"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10215852"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12387727"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12888571"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18478055"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18786924"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19748582"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20806899"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21693781"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22940918"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22988105"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23033978"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8262185"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9288916"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<sequence length="701" mass="79571" checksum="4733DBF018A4F3CD" modified="2010-05-18" version="3" precursor="true">MDLWNLSWFLFLDALLVISGLATPENFDVDGGMDQDIFDINEGLGLDLFEGDIRLDRAQIRNSIIGEKYRWPHTIPYVLEDSLEMNAKGVILNAFERYRLKTCIDFKPWAGETNYISVFKGSGCWSSVGNRRVGKQELSIGANCDRIATVQHEFLHALGFWHEQSRSDRDDYVRIMWDRILSGREHNFNTYSDDISDSLNVPYDYTSVMHYSKTAFQNGTEPTIVTRISDFEDVIGQRMDFSDSDLLKLNQLYNCSSSLSFMDSCSFELENVCGMIQSSGDNADWQRVSQVPRGPESDHSNMGQCQGSGFFMHFDSSSVNVGATAVLESRTLYPKRGFQCLQFYLYNSGSESDQLNIYIREYSADNVDGNLTLVEEIKEIPTGSWQLYHVTLKVTKKFRVVFEGRKGSGASLGGLSIDDINLSETRCPHHIWHIRNFTQFIGSPNGTLYSPPFYSSKGYAFQIYLNLAHVTNAGIYFHLISGANDDQLQWPCPWQQATMTLLDQNPDIRQRMSNQRSITTDPFMTTDNGNYFWDRPSKVGTVALFSNGTQFRRGGGYGTSAFITHERLKSRDFIKGDDVYILLTVEDISHLNSTQIQLTPAPSVQDLCSKTTCKNDGVCTVRDGKAECRCQSGEDWWYMGERCEKRGSTRDTIVIAVSSTVAVFALMLIITLVSVYCTRKKYRERMSSNRPNLTPQNQHAF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

